Evaluation of the Effect of Syringe Surfaces on Protein Formulations
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 100 (7) , 2563-2573
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin BPLOS ONE, 2010
- An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein TherapeuticsJournal of Pharmaceutical Sciences, 2010
- Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: Essential need to use orthogonal methods to assure the quality of therapeutic protein productsJournal of Pharmaceutical Sciences, 2010
- Protein adsorption and excipient effects on kinetic stability of silicone oil emulsionsJournal of Pharmaceutical Sciences, 2010
- Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous SolutionJournal of Pharmaceutical Sciences, 2009
- Precipitation of a Monoclonal Antibody by Soluble TungstenJournal of Pharmaceutical Sciences, 2009
- Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product QualityJournal of Pharmaceutical Sciences, 2009
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006
- The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringesKidney International, 2005
- Silicone Oil Induced Aggregation of ProteinsJournal of Pharmaceutical Sciences, 2005